InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Kling Douglas F. Insider active across 1 company, notably NewAmsterdam Pharma Co N.V.. Cumulatively, 10 filings have been published. Activity tracked since 26 March 2025. The latest transaction was filed on 15 July 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations
Kling Douglas F is a declarant linked to NewAmsterdam Pharma Co N.V., where the listed role is Chief Operating Officer. He has 10 filings in total, and across the 10 sampled filings the most frequent transaction nature is option exercise, with a date range from 2025-01-07 to 2025-07-17.